Japanese Encephalitis Vaccine Decision Aid for Travelers: A Randomized Clinical Trial - Summary - MDSpire

Japanese Encephalitis Vaccine Decision Aid for Travelers: A Randomized Clinical Trial

  • By

  • Sarah L. McGuinness

  • Owen Eades

  • Jennifer Morris

  • Holly Seale

  • Allen C. Cheng

  • Karin Leder

  • June 1, 2026

  • 0 min

Share

Objective:

To evaluate the impact of a web-based Japanese Encephalitis vaccine decision aid (JEVaDA) on informed vaccine decision-making and vaccine uptake among Australian travelers compared to a standard government information resource.

Key Findings:
  • The JEVaDA significantly reduced decisional conflict compared to the government information resource.
  • Participants using the JEVaDA showed improved knowledge about JE and higher intention to vaccinate.
  • Self-reported vaccine uptake was assessed approximately 2 months after the planned trip.
Interpretation:

Limitations:
  • The study may not generalize to all traveler demographics outside the Australian context.
  • Self-reported data may introduce bias in vaccine uptake reporting due to reliance on participant honesty and recall.
Conclusion:

Original Source(s)

Related Content